Physician profile
Cliff C Lin
NPI 1689963282
$1,971.90
in general payments reported to CMS, 2019-2025
20 companies · $42.38 in 2025
The $42.38 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $350 · 2021: $488 · 2022: $490 · 2023: $274 · 2025: $42.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.49 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $306.94 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $302.66 | 2019-2023 | Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $140.20 | 2019-2023 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $119.84 | 2019-2023 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $101.39 | 2020-2022 | |
| Eisai INC. | $93.15 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $88.94 | 2019-2022 | |
| Corium, LLC | $61.34 | 2022-2023 | Azstarys, Azstarys |
| Allergan, INC. | $53.30 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $44.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $42.38 | 2025 | Cobenfy |
| Adlon Therapeutics L.P. | $40.14 | 2020-2021 | |
| Axsome Therapeutics, INC. | $35.11 | 2023 | Auvelity |
| Jazz Pharmaceuticals INC. | $24.15 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.65 | 2019 | |
| Alkermes, INC. | $18.24 | 2019 | |
| Lundbeck LLC | $17.44 | 2020 | |
| Noven Therapeutics, LLC | $14.76 | 2020 | |
| Merck Sharp & Dohme LLC | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cliff Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.